The Advantages

The PrenatalSAFE® screening test has a sensitivity and specificity higher than 99% with a very low incidence of false positives, below 0.1%. 

PrenatalSAFE® KARYO Plus highlights 95.5% of fetal chromosomal aneuploidies detected at birth, achieving a level of detection rate very similar to that of traditional fetal karyotype (96.8%) and molecular karyotype (99.9%) obtained by invasive prenatal diagnosis techniques.